Trials / Completed
CompletedNCT01462305
30-Minute Light Exposure for the Treatment of Seasonal Affective Disorder
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Philips Respironics · Industry
- Sex
- All
- Age
- 21 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the effect of light therapy using a narrow 467nm light compared to a 580nm light in subjects with Seasonal Affective Disorder (SAD). It is hypothesized that the 467nm light will improve the symptoms of SAD better than the 580nm light.
Detailed description
Participants will be randomly assigned to receive either a 467nm light or a 580nm light. Participants will use the light every day for six weeks for 30 minutes. Multiple assessments and questionnaires will be given weekly to assess the efficacy of the treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | goLITE | goLITE at 30 minutes per day, within 30 minutes of waking in the morning |
| DEVICE | Control | light therapy using 580nm LED source within 30 minutes of waking in the morning every day for 6 weeks |
Timeline
- Start date
- 2012-01-06
- Primary completion
- 2012-04-02
- Completion
- 2012-04-02
- First posted
- 2011-10-31
- Last updated
- 2019-01-30
- Results posted
- 2019-01-30
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01462305. Inclusion in this directory is not an endorsement.